| Trial ID: | L4223 |
| Source ID: | NCT01545024
|
| Associated Drug: |
Sitagliptin, 50 Mg Once Per Day Per Os
|
| Title: |
Effect of DPP-IV Inhibitor on Glycemic Control and Autonomic Neuropathy in Adult Patients With Diabetes Mellitus
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Sitagliptin, 50 mg once per day per os
|
| Outcome Measures: |
Primary: Glycemic control, As marker of HbA1c, For one year after treatment wih DPP-IV inhibitor | Secondary: autonomic nerve disturbance, Before and after measurment with R-R CV in ECG at rest and respiratory deeping, Before and one year after treatment with DPP-IV inhibitor
|
| Sponsor/Collaborators: |
Sponsor: Nagaoka Red Cross Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
60
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2011-09
|
| Completion Date: |
2013-01
|
| Results First Posted: |
|
| Last Update Posted: |
2012-03-14
|
| Locations: |
Nagaoka Red Cross Hospital, Nagaoka, Niigata, 940-2085, Japan
|
| URL: |
https://clinicaltrials.gov/show/NCT01545024
|
